Failed Retrograde Transport of NGF in a Mouse Model of Down's Syndrome: Reversal of Cholinergic Neurodegenerative Phenotypes Following NGF Infusion

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 98; no. 18; pp. 10439 - 10444
• Main Authors: Cooper, Jonathan D., Salehi, Ahmad, Delcroix, Jean-Dominique, Howe, Charles L., Belichenko, Pavel V., Chua-Couzens, Jane, Kilbridge, Joshua F., Carlson, Elaine J., Epstein, Charles J., Mobley, William C.
• Format: Journal Article
• Language: English
• Published: United States National Academy of Sciences 28.08.2001; National Acad Sciences; The National Academy of Sciences
• Subjects: Aging - metabolism; Aging - pathology; Animals; Biological Sciences; Biological Transport, Active; Biology; Cell Count; Cells; Cholinergic Fibers - drug effects; Cholinergic Fibers - metabolism; Cholinergic Fibers - pathology; Cholinergics; Disease Models, Animal; Down Syndrome - drug therapy; Down Syndrome - metabolism; Down Syndrome - pathology; Downs syndrome; Forebrain; Hippocampus; Hippocampus - metabolism; Humans; Infusions, Parenteral; Internalization; Mice; Mice, Mutant Strains; Nerve Degeneration - drug therapy; Nerve Degeneration - metabolism; Nerve Degeneration - pathology; Nerve Growth Factor - administration & dosage; Nerve Growth Factor - metabolism; Neurology; Neurons; Neuroscience; Phenotype; Phenotypes; Prosencephalon - drug effects; Prosencephalon - metabolism; Prosencephalon - pathology; Receptors; Rodents; Septum; Trisomy
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.181219298

Age-related degeneration of basal forebrain cholinergic neurons (BFCNs) contributes to cognitive decline in Alzheimer's disease and Down's syndrome. With aging, the partial trisomy 16 (Ts65Dn) mouse model of Down's syndrome exhibited reductions in BFCN size and number and regressive changes in the hippocampal terminal fields of these neurons with respect to diploid controls. The changes were associated with significantly impaired retrograde transport of nerve growth factor (NGF) from the hippocampus to the basal forebrain. Intracerebroventricular NGF infusion reversed well established abnormalities in BFCN size and number and restored the deficit in cholinergic innervation. The findings are evidence that even BFCNs chronically deprived of endogenous NGF respond to an intervention that compensates for defective retrograde transport. We suggest that age-related cholinergic neurodegeneration may be a treatable disorder of failed retrograde NGF signaling.